Metformin in the treatment of patients w
β
A. Uygun; A. Kadayifci; A. T. Isik; T. Ozgurtas; S. Deveci; A. Tuzun; Z. Yesilov
π
Article
π
2004
π
John Wiley and Sons
π
English
β 77 KB
## Summary **Background** :βIncreased insulin resistance is the major pathogenic mechanism in the development of nonβalcoholic steatohepatitis. **Aim** :βTo investigate the therapeutic effect of metformin, a wellβknown insulinβsensitizing agent, in the treatment of nonβalcoholic steatohepatitis.